131 related articles for article (PubMed ID: 34677924)
21. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.
Ghia T; Kanhangad M; Alessandri AJ; Price G; Gera P; Nagarajan L
Pediatr Neurol; 2016 Feb; 55():68-70. PubMed ID: 26778146
[TBL] [Abstract][Full Text] [Related]
22. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
23. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?
Paliwal VK; Chandra S; Verma R; Kalita J; Misra UK
J Neural Transm (Vienna); 2010 May; 117(5):613-5. PubMed ID: 20094737
[TBL] [Abstract][Full Text] [Related]
24. Opsoclonus-myoclonus syndrome attributable to hepatitis C infection.
Ertekin V; Tan H
Pediatr Neurol; 2010 Jun; 42(6):441-2. PubMed ID: 20472199
[TBL] [Abstract][Full Text] [Related]
25. "Pediatrician's Approach to Recognizing Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome".
Segal JE; Ritchey AK; Tersak J; Thakkar K; Lambore S
Clin Pediatr (Phila); 2023 Sep; 62(8):820-823. PubMed ID: 36579856
[No Abstract] [Full Text] [Related]
26. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
Anand S; Agarwala S; Jain V; Bakhshi S; Dhua A; Gulati S; Seth R; Srinivas M; Jana M; Kandasamy D; Bhatnagar V
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e924-e929. PubMed ID: 33769388
[TBL] [Abstract][Full Text] [Related]
27. Update on opsoclonus-myoclonus syndrome in adults.
Oh SY; Kim JS; Dieterich M
J Neurol; 2019 Jun; 266(6):1541-1548. PubMed ID: 30483882
[TBL] [Abstract][Full Text] [Related]
28. Opsoclonus-myoclonus syndrome.
Pike M
Handb Clin Neurol; 2013; 112():1209-11. PubMed ID: 23622330
[TBL] [Abstract][Full Text] [Related]
29. [Opsoclonus-myoclonus syndrome].
Arroyo HA; Tringler N
Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome.
Fukushima H; Inoue T; Takama Y; Ishii N; Okuno T; Kobayashi Y; Yoneda A; Nakamura T; Kuki I; Hara J
Pathol Int; 2017 Oct; 67(10):503-509. PubMed ID: 28971571
[TBL] [Abstract][Full Text] [Related]
31. [Post-malarial opsoclonus-myoclonus-ataxia syndrome: a paediatric case].
Suárez-Galvis MM; Benjumea-Cuartas V; Mesa-Restrepo SC; Cabrera D
Rev Neurol; 2011 Apr; 52(7):444-6. PubMed ID: 21425115
[No Abstract] [Full Text] [Related]
32. An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy.
Stiefel J; Basu E; Meyer R; Kaur G; Khakoo Y
Pediatr Blood Cancer; 2020 Nov; 67(11):e28393. PubMed ID: 32798258
[No Abstract] [Full Text] [Related]
33. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
[TBL] [Abstract][Full Text] [Related]
34. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
35. A Toddler With Uncontrollable Shaking After a Minor Fall.
Wu H; Mody AP
Pediatr Emerg Care; 2017 Oct; 33(10):e95-e97. PubMed ID: 26466152
[TBL] [Abstract][Full Text] [Related]
36. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome.
Brunklaus A; Pohl K; Zuberi SM; de Sousa C
Arch Dis Child; 2012 May; 97(5):461-3. PubMed ID: 21460401
[TBL] [Abstract][Full Text] [Related]
37. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.
Mizia-Malarz A; Stolpa W; Sobol-Milejska G
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823831
[No Abstract] [Full Text] [Related]
38. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
Chang BH; Koch T; Hopkins K; Malempati S
Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar ataxia and opsoclonus as the initial manifestations of myoclonic encephalopathy associated with neuroblastoma.
Harel S; Yurgenson U; Rechavi G; Burstein Y; Spirer Z
Childs Nerv Syst; 1987; 3(4):245-7. PubMed ID: 3690566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
